Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,745 | 190 | 99.6% |
| Education | $24.21 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,128 | 47 | $0 (2023) |
| GlaxoSmithKline, LLC. | $948.33 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $605.89 | 16 | $0 (2022) |
| PFIZER INC. | $538.15 | 21 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $394.95 | 18 | $0 (2021) |
| Novo Nordisk Inc | $265.82 | 9 | $0 (2022) |
| Lilly USA, LLC | $263.42 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $238.63 | 8 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $161.86 | 11 | $0 (2020) |
| Medtronic Vascular, Inc. | $144.05 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $273.29 | 5 | GlaxoSmithKline, LLC. ($125.00) |
| 2023 | $582.59 | 19 | Janssen Pharmaceuticals, Inc ($227.94) |
| 2022 | $832.22 | 26 | AstraZeneca Pharmaceuticals LP ($214.35) |
| 2021 | $634.16 | 26 | GlaxoSmithKline, LLC. ($159.38) |
| 2020 | $362.06 | 17 | Janssen Pharmaceuticals, Inc ($120.86) |
| 2019 | $674.46 | 26 | PFIZER INC. ($209.64) |
| 2018 | $912.07 | 24 | Janssen Pharmaceuticals, Inc ($277.90) |
| 2017 | $1,498 | 50 | Novartis Pharmaceuticals Corporation ($329.80) |
All Payment Transactions
193 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ortho-Clinical Diagnostics, Inc. | — | Food and Beverage | In-kind items and services | $18.96 | General |
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Ortho-Clinical Diagnostics, Inc. | — | Food and Beverage | In-kind items and services | $81.76 | General |
| 09/30/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Diabetes | ||||||
| 09/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $128.13 | General |
| 09/07/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 06/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/31/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/19/2023 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 05/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $110.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/20/2023 | Almatica Pharma LLC | GRALISE (Drug), SERTRALINE HCL, LOREEV XR | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 01/19/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: Cardiovascular | ||||||
| 12/13/2022 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $37.25 | General |
| Category: Coronary | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 795 | 1,308 | $86,332 | $33,545 |
| 2022 | 21 | 806 | 1,247 | $85,091 | $35,306 |
| 2021 | 19 | 820 | 1,422 | $109,341 | $40,381 |
| 2020 | 22 | 1,263 | 2,010 | $150,434 | $59,581 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 225 | $25,861 | $13,335 | 51.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $7,876 | $5,621 | 71.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 86 | 178 | $8,900 | $1,833 | 20.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 13 | 14 | $4,900 | $1,827 | 37.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 91 | 186 | $5,580 | $1,401 | 25.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 21 | 29 | $1,450 | $1,139 | 78.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 29 | $3,335 | $1,102 | 33.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,100 | $1,013 | 48.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 65 | 73 | $3,285 | $946.33 | 28.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 39 | 54 | $3,240 | $888.84 | 27.4% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 38 | 52 | $5,200 | $863.20 | 16.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 42 | 42 | $819.49 | $773.03 | 94.3% |
| 82948 | Blood glucose (sugar) measurement using reagent strip | Office | 2023 | 32 | 112 | $1,790 | $548.74 | 30.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 39 | 53 | $5,300 | $468.52 | 8.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 44 | $2,420 | $451.57 | 18.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 35 | 46 | $1,380 | $437.92 | 31.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 21 | 21 | $630.00 | $353.80 | 56.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 12 | 24 | $1,200 | $198.96 | 16.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 31 | 33 | $495.00 | $130.02 | 26.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 18 | 19 | $285.00 | $116.09 | 40.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 18 | 19 | $285.00 | $96.52 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 233 | $27,713 | $14,731 | 53.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 55 | 55 | $10,065 | $7,400 | 73.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 95 | 177 | $8,850 | $1,844 | 20.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 98 | 185 | $5,550 | $1,418 | 25.5% |
About Dr. Mohan Gupta, MD
Dr. Mohan Gupta, MD is a Internal Medicine healthcare provider based in Sunrise, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295791994.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohan Gupta, MD has received a total of $5,769 in payments from pharmaceutical and medical device companies, with $273.29 received in 2024. These payments were reported across 193 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,745).
As a Medicare-enrolled provider, Gupta has provided services to 3,684 Medicare beneficiaries, totaling 5,987 services with total Medicare billing of $168,813. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Sunrise, FL
- Active Since 04/22/2006
- Last Updated 12/07/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1295791994
Products in Payments
- XARELTO (Drug) $960.27
- ENTRESTO (Drug) $394.95
- ELIQUIS (Drug) $365.16
- TRELEGY ELLIPTA (Drug) $253.00
- FARXIGA (Drug) $233.11
- BREZTRI (Drug) $208.58
- INVOKANA (Drug) $167.59
- CoreValve Evolut (Device) $144.05
- MOUNJARO (Drug) $141.89
- JARDIANCE (Drug) $140.38
- JANUVIA (Drug) $132.09
- BYDUREON (Drug) $125.01
- AREXVY (Drug) $125.00
- GIAPREZA (Drug) $125.00
- Rybelsus (Drug) $124.99
- NUCALA (Biological) $115.10
- Ranexa (Drug) $110.92
- INCRUSE (Drug) $98.97
- CHANTIX (Drug) $98.20
- Yupelri (Drug) $91.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sunrise
Howard Koch, Md, MD
Internal Medicine — Payments: $54,238
Soling Li, D.o, D.O
Internal Medicine — Payments: $22,810
Faride Ramos, M.d, M.D
Internal Medicine — Payments: $3,190
Dr. Kliti Tane, M.d, M.D
Internal Medicine — Payments: $3,110
Dr. Medhat Awad, M.d, M.D
Internal Medicine — Payments: $2,891
Dr. Ludwig Pierre, M.d, M.D
Internal Medicine — Payments: $2,201